Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karine Botturi

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Respiratory Research|March 2, 2011
Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4Karine Botturi, Yannick Lacoeuille, Arnaud Cavaillès, et al.
Respiratory Medicine|February 14, 2009
Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacyAnaïs Pipet, Karine Botturi, Domitille Pinot, et al.
Presse Medicale (Paris, France : 1983)|December 11, 2007
[Exacerbation in asthma: definitions and immunopathology]Arnaud Cavaillès, Domitille Pinot, Ana Nieves, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 5, 2014
Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotypeMallory Pain, Olga Bermudez, Philippe Lacoste, et al.
Pharmacology & Therapeutics|March 29, 2011
Preventing asthma exacerbations: what are the targets?Karine Botturi, Marie Langelot, David Lair, et al.
Plos One|October 21, 2014
Systematic analysis of blood cell transcriptome in end-stage chronic respiratory diseasesJulie Chesné, Richard Danger, Karine Botturi, et al.
Trials|March 22, 2021
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trialBenjamin Gaborit, Bernard Vanhove, Marie-Anne Vibet, et al.
The European Respiratory Journal|January 20, 2017
Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) studyMeriem Benmerad, Rémy Slama, Karine Botturi, et al.
Frontiers in Immunology|January 30, 2018
Blood Gene Expression Predicts Bronchiolitis Obliterans SyndromeRichard Danger, Pierre-Joseph Royer, Damien Reboulleau, et al.
Frontiers in Medicine|August 4, 2017
Development of a Multivariate Prediction Model for Early-Onset Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome in Lung TransplantationAngela Koutsokera, Pierre J Royer, Jean P Antonietti, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Respiratory Research|March 2, 2011
Differences in allergen-induced T cell activation between allergic asthma and rhinitis: Role of CD28, ICOS and CTLA-4Karine Botturi, Yannick Lacoeuille, Arnaud Cavaillès, et al.
Respiratory Medicine|February 14, 2009
Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacyAnaïs Pipet, Karine Botturi, Domitille Pinot, et al.
Presse Medicale (Paris, France : 1983)|December 11, 2007
[Exacerbation in asthma: definitions and immunopathology]Arnaud Cavaillès, Domitille Pinot, Ana Nieves, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|March 5, 2014
Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotypeMallory Pain, Olga Bermudez, Philippe Lacoste, et al.
Pharmacology & Therapeutics|March 29, 2011
Preventing asthma exacerbations: what are the targets?Karine Botturi, Marie Langelot, David Lair, et al.
Plos One|October 21, 2014
Systematic analysis of blood cell transcriptome in end-stage chronic respiratory diseasesJulie Chesné, Richard Danger, Karine Botturi, et al.
Trials|March 22, 2021
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trialBenjamin Gaborit, Bernard Vanhove, Marie-Anne Vibet, et al.
The European Respiratory Journal|January 20, 2017
Chronic effects of air pollution on lung function after lung transplantation in the Systems prediction of Chronic Lung Allograft Dysfunction (SysCLAD) studyMeriem Benmerad, Rémy Slama, Karine Botturi, et al.
Frontiers in Immunology|January 30, 2018
Blood Gene Expression Predicts Bronchiolitis Obliterans SyndromeRichard Danger, Pierre-Joseph Royer, Damien Reboulleau, et al.
Frontiers in Medicine|August 4, 2017
Development of a Multivariate Prediction Model for Early-Onset Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome in Lung TransplantationAngela Koutsokera, Pierre J Royer, Jean P Antonietti, et al.
Pageof 2